Identifying Factors Predicting ACcurately End-of-Life in Dementia with Lewy Bodies and Promoting Quality End-of-Life Experiences: the PACE-DLB Study
识别准确预测路易体痴呆症临终的因素并提升临终体验质量:PACE-DLB 研究
基本信息
- 批准号:10404687
- 负责人:
- 金额:$ 63.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-15 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAffectAgeAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAreaBehavioralBehavioral SymptomsBereavementCaregiver BurdenCaregiver well-beingCaregiversCaringCenters of Research ExcellenceCessation of lifeCharacteristicsChildClimactericClinicalCognitiveCohort StudiesCollaborationsCounselingDataData SetDatabasesDementiaDementia with Lewy BodiesDemographic ImpactDiscipline of NursingEnrollmentFaceFailure to ThriveFamilyFutureGrief reactionGuidelinesHallucinationsHealth PersonnelHealthcareHomeIndividualInterventionKnowledgeLewy Body DementiaLifeLife ExperienceLocationLongitudinal cohort studyMeasuresMedicalMedicareMental DepressionModelingMotorMovement Disorder Society Unified Parkinson&aposs Disease Rating ScaleNational Institute on AgingOutcomePatientsPersonsPhysiciansPneumoniaPopulationPredictive FactorProviderPublishingQuality of CareQuality of lifeRecoveryReportingRuralSelf EfficacySeriesSeveritiesSignal TransductionSleepSocial supportSpecialistSpousesSymptomsTelephoneUnited StatesVisitbasecohortcomorbiditycopingdecubitus ulcerdemographicsend of lifeend of life careevidence baseexperiencehospice environmentimprovedinformal caregivermedical specialtiesneurodegenerative dementianovelrecruitresidenceresiliencesatisfactionsuburbtoolvirtual
项目摘要
PROJECT SUMMARY/ABSTRACT
Dementia with Lewy bodies (DLB) is part of Lewy body dementia, the 2nd-most-common degenerative
dementia in the U.S. It is also one of the Alzheimer’s disease-related dementias (ADRDs). Evidence-based
models of end-of-life care for ADRDs are insufficient; families face difficult medical decisions with little
information for guidance. This is particularly relevant for DLB, where >70% of individuals die of the dementia
itself or failure to thrive. Caregivers describe lack of knowledge of what to expect at the end of life as an
important driver of negative end-of-life experiences. The proposed study addresses this unmet need. It also
addresses the National Institute on Aging’s priority to improve quality of care and quality of life for persons with
ADRDs at the end of life and their caregivers. This study aims to (1) determine the predictors of death within 6
months in individuals with DLB, (2) identify whether a change in caregiver measures can predict approaching
end of life of individuals with DLB, and (3) identify factors that affect quality end of life experiences for persons
with DLB and their caregivers. These aims will be accomplished through a longitudinal cohort study enrolling
dyads of individuals with DLB of at least moderate dementia severity and their caregivers. Dyads will attend
study visits every 6 months through the end of life or 3 years. Based on published clinical series, over half of
enrolled individuals with DLB are expected to die over the course of the study. To achieve diverse recruitment,
the study includes an in-person cohort where dyads are recruited from Lewy Body Dementia Association
Research Centers of Excellence and a novel virtual cohort where dyads are recruited through the Lewy Body
Dementia Association and study visits are conducted by telephone. Having a virtual cohort will capture the
experiences of individuals with DLB and caregivers not receiving care at specialty centers. Because the
majority of study measures are caregiver-reported, the in-person and virtual groups have identical study
measures, except for the Unified Parkinson Disease Rating Scale, completed only in person. Collected
measures will include demographics, DLB characteristics (e.g. cognitive, motor, behavioral, sleep, and
autonomic symptoms), health care providers and settings, caregiver considerations (e.g. resilience, support,
grief, burden), quality of life (for the patient and caregiver), and satisfaction with end of life experiences. The
caregiver will complete a final study visit 3 months after the death of the person with DLB to assess grief,
recovery, and quality of the end of life experience. By following dyads through the end of life and death of the
person with DLB and the initial bereavement period for the caregiver, the study will identify DLB-specific
predictors of the last 6 months of life, changes in caregiver measures that identify the last 6 months of life, and
factors which influence quality end of life experiences. These results will inform the content and timing of end-
of-life counseling in DLB, help establish quality metrics for end of life care, and identify areas where
interventions could potentially improve end of life experiences for individuals with DLB and their caregivers.
项目总结/摘要
路易体痴呆(DLB)是路易体痴呆的一部分,路易体痴呆是第二常见的退行性痴呆,
它也是阿尔茨海默病相关痴呆症(ADRD)之一。循证
ADRD的临终关怀模式不足;家庭面临困难的医疗决定,
信息指导。这与DLB特别相关,其中>70%的个体死于痴呆症
本身或未能蓬勃发展。照顾者描述缺乏知识的期望在生命的最后,
消极的临终体验的重要驱动因素。拟议的研究解决了这一未满足的需求。它还
解决了国家老龄问题研究所的优先事项,以提高护理质量和生活质量的人,
ADRD患者及其护理人员。本研究的目的是(1)确定6岁以内死亡的预测因素
(2)确定照顾者措施的变化是否可以预测接近
DLB个体的生命结束,以及(3)确定影响人的生命结束体验质量的因素
与DLB和他们的护理人员。这些目标将通过招募纵向队列研究来实现
患有至少中度痴呆严重程度的DLB的个体及其照顾者的二人组。戴雅兹将出席
每6个月进行一次研究访视,直至生命结束或3年。根据已发表的临床系列,超过一半的
预期登记的DLB个体在研究过程中死亡。为实现多元化招聘,
这项研究包括一个面对面的队列,其中从路易体痴呆协会招募了二人组
卓越的研究中心和一个新的虚拟队列,其中通过路易体招募二人组
痴呆症协会和研究访问通过电话进行。拥有一个虚拟队列将捕获
DLB患者和未在专科中心接受护理的护理人员的经验。因为
大多数研究措施是双向报告的,面对面和虚拟组的研究相同
测量,除了统一帕金森病评定量表,仅亲自完成。收集
测量将包括人口统计学、DLB特征(如认知、运动、行为、睡眠和
自主症状),健康护理提供者和环境,护理者考虑因素(例如弹性,支持,
悲伤、负担)、生活质量(对于患者和护理者)以及对生命结束体验的满意度。的
护理者将在患有DLB的人死亡后3个月完成最终研究访视以评估悲伤,
恢复和生命结束体验的质量。通过跟踪二人组的生命和死亡的结束
DLB患者和护理人员的初始丧亲期,研究将确定DLB特异性
生命最后6个月的预测因素,确定生命最后6个月的护理人员测量的变化,以及
影响生命体验质量的因素。这些结果将告知结束的内容和时间-
在DLB的生命咨询,帮助建立生命终了护理的质量指标,并确定领域,
干预措施可能会改善DLB患者及其护理人员的临终体验。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Melissa Jo Armstrong其他文献
Melissa Jo Armstrong的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Melissa Jo Armstrong', 18)}}的其他基金
Identifying Factors Predicting ACcurately End-of-Life in Dementia with Lewy Bodies and Promoting Quality End-of-Life Experiences: the PACE-DLB Study
识别准确预测路易体痴呆症临终的因素并提升临终体验质量:PACE-DLB 研究
- 批准号:
10380453 - 财政年份:2020
- 资助金额:
$ 63.05万 - 项目类别:
Identifying Factors Predicting ACcurately End-of-Life in Dementia with Lewy Bodies and Promoting Quality End-of-Life Experiences: the PACE-DLB Study
识别准确预测路易体痴呆症临终的因素并提升临终体验质量:PACE-DLB 研究
- 批准号:
10256657 - 财政年份:2020
- 资助金额:
$ 63.05万 - 项目类别:
Identifying Factors Predicting ACcurately End-of-Life in Dementia with Lewy Bodies and Promoting Quality End-of-Life Experiences: the PACE-DLB Study
识别准确预测路易体痴呆症临终的因素并提升临终体验质量:PACE-DLB 研究
- 批准号:
10522213 - 财政年份:2020
- 资助金额:
$ 63.05万 - 项目类别:
Identifying Factors Predicting ACcurately End-of-Life in Dementia with Lewy Bodies and Promoting Quality End-of-Life Experiences: the PACE-DLB Study
识别准确预测路易体痴呆症临终的因素并提升临终体验质量:PACE-DLB 研究
- 批准号:
10621190 - 财政年份:2020
- 资助金额:
$ 63.05万 - 项目类别:
1Florida Alzheimer's Disease Research Center Clinical Core
1佛罗里达阿尔茨海默病研究中心临床核心
- 批准号:
10663218 - 财政年份:2020
- 资助金额:
$ 63.05万 - 项目类别:
Identifying Factors Predicting ACcurately End-of-Life in Dementia with Lewy Bodies and Promoting Quality End-of-Life Experiences: the PACE-DLB Study
识别准确预测路易体痴呆症临终的因素并提升临终体验质量:PACE-DLB 研究
- 批准号:
10028564 - 财政年份:2020
- 资助金额:
$ 63.05万 - 项目类别:
Enhancing Clinical Guideline Development via Patient and Stakeholder Engagement
通过患者和利益相关者的参与加强临床指南的制定
- 批准号:
8951631 - 财政年份:2015
- 资助金额:
$ 63.05万 - 项目类别:
Interdisciplinary Training in Movement Disorders and Neurorestoration
运动障碍和神经恢复的跨学科培训
- 批准号:
10615144 - 财政年份:2015
- 资助金额:
$ 63.05万 - 项目类别:
Interdisciplinary Training in Movement Disorders and Neurorestoration
运动障碍和神经恢复的跨学科培训
- 批准号:
10449128 - 财政年份:2015
- 资助金额:
$ 63.05万 - 项目类别:
Enhancing Clinical Guideline Development via Patient and Stakeholder Engagement
通过患者和利益相关者的参与加强临床指南的制定
- 批准号:
9293963 - 财政年份:2015
- 资助金额:
$ 63.05万 - 项目类别:
相似海外基金
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
- 批准号:
495182 - 财政年份:2023
- 资助金额:
$ 63.05万 - 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
- 批准号:
2601817 - 财政年份:2021
- 资助金额:
$ 63.05万 - 项目类别:
Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
- 批准号:
2029039 - 财政年份:2020
- 资助金额:
$ 63.05万 - 项目类别:
Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
- 批准号:
9888417 - 财政年份:2019
- 资助金额:
$ 63.05万 - 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
- 批准号:
17K11318 - 财政年份:2017
- 资助金额:
$ 63.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9320090 - 财政年份:2017
- 资助金额:
$ 63.05万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
10166936 - 财政年份:2017
- 资助金额:
$ 63.05万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9761593 - 财政年份:2017
- 资助金额:
$ 63.05万 - 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
- 批准号:
BB/M50306X/1 - 财政年份:2014
- 资助金额:
$ 63.05万 - 项目类别:
Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
- 批准号:
288272 - 财政年份:2013
- 资助金额:
$ 63.05万 - 项目类别:
Miscellaneous Programs